1NE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Verrica Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 3.5 EUR -2.78% Market Closed

Market Cap: €148.5m

V	Verrica Pharmaceuticals Inc F:1NE	US
	Zydus Lifesciences Ltd BSE:532321	IN
	Tsingtao Brewery Co Ltd F:TSI	CN
T	TAG Immobilien AG F:TEG	DE
	Unilever Indonesia Tbk PT F:UTG	ID
	Mercedes-Benz Group AG SIX:MBG	DE
	MLP SE F:MLP	DE
K	Koninklijke Philips NV SWB:PHI1	NL
	VNV Global AB (publ) F:82K	SE
	Oracle Power PLC F:9OC	UK

Profitability Summary

Verrica Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

64%

Gross Margin is Increasing

-8% > 90%

Negative Operating Margin

-34%

Negative 3Y Average Operating Margin

-633%

Operating Margin is Increasing

-259% > -34%

Negative Net Margin

-50%

Negative 3Y Average Net Margin

-683%

Net Margin is Increasing

-262% > -50%

Negative Free Cash Flow Margin

-50%

Negative 3Y Average Free Cash Flow Margin

-479%

Free Cash Flow Margin is Increasing

-176% > -50%

Negative ROE

-240%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-428%

Declining ROIC

-78% > -115%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.